Ireland-U.S. Council honour Randox founder with Business Relations Award
The Ireland-U.S. Council in America have this week presented the founder of healthcare diagnostics company Randox Laboratories with an award marking significant achievement in building relations between Northern Ireland and the United States of America.
Presented to Dr Peter FitzGerald at the 56th Annual Dinner of the Ireland-U.S. Council yesterday evening, the accolade, named the Cúchulainn award, recognizes the efforts of individuals who go above and beyond to support the objectives of the Ireland-U.S. Council – to improve the business bonds and commercial connections between Ireland, Northern Ireland and the United States.
Joining an exclusive line-up of some of the most prominent business figures in both Ireland and the United States recognized by the Ireland-U.S. Council, including CEO of International Airlines Group William Walsh, Dr FitzGerald was presented with the prestigious award at The Metropolitan Club in New York City.
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“I am most honoured to be here this evening to accept the Cúchulainn award from the Ireland-U.S. Council in recognition of the work undertaken by Randox in the United States since the early 1980s when we began to export our diagnostic healthcare products. The United States remains one of Randox’s most important markets, in which we are growing at pace thanks to the ongoing development of innovative new products in not only the healthcare sector, but also the veterinary, research, toxicology and food safety industries.”
The Ireland-U.S. Council was founded in 1962 by a group of American and Irish business leaders as a measure to build an established structure which would encourage closer economic relations, and was initially created to assist in making preparations for the first-ever State Visit of a sitting U.S. President to Ireland by President John F. Kennedy from June 26 – 29 in 1963.
David O’Sullivan, Executive Director of the Ireland–U.S. Council, added;
“Ever since the State Visit to Ireland by President John F. Kennedy, the Ireland-U.S. Council has been engaged in efforts to achieve our transatlantic mission. Dr FitzGerald of Randox Laboratories truly embodies the essence of this mission by aligning his business in Ireland closely with businesses in the US, to maximise the positive outcomes for both parties. We are delighted to present him this evening with the Cúchulainn award – for the significant contributions he has made to the development of closer economic, business and commercial ties between our two nations.”
For further information please email email@example.com
World-leading medical diagnostics manufacturer Randox Laboratories is this week showcasing advancements in biotechnology at the world’s largest diagnostics conference, being held in Chicago, Illinois.
The American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, known as the leading event for laboratory medicine worldwide, offers Randox the opportunity to showcase their capabilities to more than 20,000 healthcare professionals and decision makers from around the globe.
“Our pioneering diagnostic technologies are leading the way in innovation and have real potential to transform healthcare around the world,” said Randox Managing Director, Dr Peter FitzGerald.
“At AACC we will be hosting demonstrations of a wide range of our intuitive multiplex analysers, including the revolutionary Randox Evidence Evolution, the world’s first fully automated random-access testing platform, capable of delivering 2640 results in one hour, with the first delivered in just 37 minutes.”
The unique and unrivalled capabilities of the Randox Evidence Evolution are made possible thanks to Randox’s patented Biochip Array Technology, which can currently run 49 different tests simultaneously – ensuring an accurate and reliable diagnosis as fast as possible.
Launching at this year’s AACC event are a number of exciting new tests on the Randox Biochip, the result of a £280 million investment in research and development. Including but not exclusive to a diagnostic test for the differentiation of hemorrhagic and ischemic strokes, an algorithm capable of generating a patient’s Type 1 Diabetes Genetic Risk Score, and a test to diagnose Acute Kidney Injury (AKI) in the participants of pharmaceutical drug trials, these new tests all share the common goal of much earlier and effective diagnosis, to greatly improve healthcare outcomes and reduce the burden on healthcare services.
Dr. FitzGerald continued;
“We remain committed to developing new health diagnostic technologies for a range of the world’s most pressing health issues in need of the most urgent address, and to expanding the business in our key markets, such as the US.
“Our very significant investment in research and development means that we have more new tests in development than any other healthcare company in the world and are able each year to bring a wealth of exciting new technologies to the American market.
“We look forward to showcasing our latest innovations at this year’s AACC conference, and how they can be utilised to save, improve and extend lives through the earliest possible diagnosis. Randox technology can truly revolutionise the future of healthcare.”
AACC runs from the 29th July – 2nd August at McCormick Place in Chicago, Illinois. Randox can be found at booth #3624.
For further information visit aacc.randox.com
Mycotoxin contamination is a real and constant threat for feed and animal compound producers globally. Recently the University of Guelph, Guelph, Ontairo stated that the different geographical locations of cattle mean between 10 and 20 mycotoxins can be present at once. This is a result of extreme weather patterns across the US with excess moisture and drought in different areas causing an increase in the frequency of mycotoxins, creating challenges in protecting livestock from ingesting contaminated feed.
The most common mycotoxins found are Aflatoxin, Fusarium, Deoxynivalenol and Zearalenone. Aflatoxin is produced by Aspergillus flavus, a tropical fungus that thrives in high humidity and affects an animal’s liver, causing cancer in more extreme cases. Fusarium can develop in most temperate climates across the U.S and Canada. Fusarium poses a higher threat than other toxins as there are hundreds of different chemical structures to analyse to enable identification of the Fusarium.
Difficulties also arise in finding an analytical method sensitive enough to detect mycotoxins at low levels of contamination as small amounts can still lead to fatal results in horses, dogs and cats.
To prevent mycotoxin infection in feed, processors can implement a routine screening procedure with the help of Randox Food Diagnostics. Randox Food offer a multiplex screening system for the simultaneous detection of up to 10 of the world’s most prevalent mycotoxins including: Paxilline, Fumonisins (part of the Fusarium group), Ochratoxin A, Aflatoxin G1/G2, Aflatoxin B1/B2, Ergot Alkaloids, Diacetoxyscirpenol, Deoxynivalenol, T2 Toxin and Zearalenone. All compounds are screened at low limits of detection using Biochip Array Technology.
Biochip Array Technology is a patented technology created by Randox to facilitate the detection of contaminants and drug residues with over 20 evaluated matrices in feed (see full list below).
|Animal Feed (Complete)||Millet||Sunflower|
|Cotton Seed||Rye||Feed Pea|
|Distillers Grain||Silage||Vetches (Vica)|
A group of 30 delegates from global healthcare company Randox Laboratories has this week travelled to the USA, to take part in the world’s largest diagnostics conference – in San Diego, California.
The American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, known as the leading event for laboratory medicine worldwide, is attended by over 20,000 delegates from across the globe, and offers Randox the opportunity to showcase their capabilities and to network with leading healthcare professionals and key decision makers.
Launching at this year’s event are a number of innovative and exciting new products, including a test for Acute Kidney Injury, a revolutionary diagnostic for small, dense low density lipoprotein (sLDL), a subtype of LDL cholesterol which is a vital risk marker for cardiovascular disease, and the latest in laboratory quality assurance software.
Chief Scientist at Randox Laboratories, John Lamont, who is heading up the delegation to the US, commented;
“Our very significant investment in research and development means that we have more new tests in development than any other healthcare company in the world. Each year at AACC we are able to bring a wealth of exciting new technologies to the American market, for a range of the world’s pressing health issues in need of the most urgent address. We look forward to showcasing our latest innovations at this year’s AACC conference, and to identifying further potential projects.”
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“We appreciate that post-Brexit there will of course be particular business challenges with regards to international business, but at Randox we will remain committed to developing new health diagnostic technologies in the areas where they are needed most, and to expanding the business in our key markets, such as the US.
“The USA is one of our most important markets and we have been exporting our diagnostic products there since the early 1980s. We will continue to nurture our presence there, the expansion of which will be supported by our soon to be opened facility in Kearneysville, West Virginia, which will enable us to strengthen our position in that market.”
AACC runs from the 30th July – 3rd August at the San Diego Convention Centre. Randox can be found at booth #3839.
For further information about Randox at AACC please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Global healthcare company Randox, which is headquartered in Co Antrim and has key R&D, engineering and manufacturing facilities in both Co Antrim and Co Donegal, has been named in The US-Ireland Top 50 Companies, to be announced today, Friday 16th June, at the New York/New Belfast conference in Manhattan.
With a focus on the transatlantic operations building bridges between the two countries, the awards celebrate those bringing business in Ireland to global heights in the belief that by doing so they are embedding peace for future generations.
The 50 honourees will be announced at a gala event hosted by the Irish Echo, the USA’s largest and most widely read Irish American weekly paper, at Pier A, Harbor House.
The tenth annual celebration will be addressed by Constance Hunter, Chief Economist of KPMG and Daniel Dromm, NYC City Council member and Chair of the Education Committee, and takes place as part of the two-day conference. This prestigious event highlights the progress and prosperity of both cities, and looks optimistically to the future while celebrating our shared past.
Movie makers, scientists, tech companies and engineers have been among those who have received the plaudit in recent years. They have included the all-conquering production company, HBO; leading law firm A&L Goodbody; pioneers in scientific imaging Andor Technology and the New York Stock Exchange.
This year’s US-Ireland Top 50 has proven to be just as illustrious with Randox Laboratories, Northern Property, Norwegian Airlines, and Bank of Ireland as just some of the companies being recognised for their success.
Editor of the Irish Echo, Ray O’Hanlon, who will host Friday’s event, said the awards were an acknowledgment of the unique bonds between the two nations.
“The unmistakable and unbreakable bonds between Ireland and the United States have proven a key element in Ireland’s progression, both in terms of peace and prosperity. Those bonds grow ever stronger when underpinned by economic growth and business relationships. With the Ireland-US Top 50 we acknowledge those companies whose transatlantic operations support that ongoing development and welcome them to this illustrious list of business beacons.”
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“The US is one of our most important markets and we have been exporting our diagnostic products there since the early 1980s. We have seen substantial success in this market and have secured for example, key clinical chemistry analyser contracts in Ivy League Institutions such as Yale University School of Medicine and Harvard University.
“Our diversification into the veterinary, research, forensic and food safety sectors has enabled our operations in the US to expand further still, and due to this increasing demand for Randox innovations, we are developing a new facility in the Greater Washington DC area.
“It is a tribute to the entire Randox team, both in Co Antrim and Co Donegal, that we have been named as one of the US-Ireland Top 50. We hope to serve as an example to other aspiring businesses that success is possible with a unique product offering, a commitment to investment, and making use of the support network available across the United States.”
For further information about the New York New Belfast Conference contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Alongside Complete Lab Solutions and Eirecomposites Teo from Galway, Westire Technology Teo from Mayo, and the National University of Ireland Galway, Randox Teoranta is taking part in Údarás na Gaeltachta’s third visit to the Irish Chamber, to showcase the business and job opportunities available in the Irish-speaking Gaeltacht.
The event was launched last night with a welcome reception in the prestigious Pyramid Club of Philadelphia, with a number of presentations, seminars and networking opportunities taking place during today’s session at The Union League of Philadelphia.
Senior Manager of Randox Laboratories, Mark Campbell, who is attending the Symposium in Philadelphia, is looking forward to showcasing what Donegal has to offer, meeting potential business partners and finding new investment opportunities;
“It is a great honour and privilege to join Údarás na Gaeltachta on their Trade Mission and to represent businesses within Donegal at the Symposium. Not only do we have key diagnostics capabilities of interest to the US, we also want to let the wider Irish diaspora know that there are world-leading career opportunities on offer in Donegal, including those in the life sciences, engineering and software development industries. Our revolutionary diagnostics simultaneously allow us to partner with like-minded innovators in markets overseas, and to create further employment at home.”
In 2015 Randox Teoranta in Donegal announced an investment of €25 million to extend and develop the R&D and manufacturing facilities of the state-of-the-art biotech facility. The investment in the site will accelerate the development of new products into a wide range of clinical needs, including various cancers, stroke, heart disease and neurodegenerative disorders.
“Interest in Donegal as an exciting place to live and work has grown significantly in recent times. In the past year alone Donegal Airport was voted one of the world’s most scenic airports, and the National Geographic Traveller named Donegal the coolest place on the planet.
“Our Randox site in Dungloe has much to offer the US and we are looking forward to sharing our innovative diagnostic technologies and our world-class careers with the members of the Irish American Business Chamber and Network.”
Mícheál Ó hÉanaigh, Director of Enterprise, Employment and Property, Údarás na Gaeltachta, is heading up the delegation to Philadelphia, and commented;
“Údarás na Gaeltachta are delighted to have the opportunity to showcase all of our Gaeltacht areas at the Irish American Business Chamber and Network Symposium. Our Diaspora are an essential element in attracting business and employment home to Ireland and to our Gaeltacht areas, a lot of which are located in remote and peripheral areas. We are very proud to be able share a platform with and showcase a cross section of our excellent client companies such as Randox who reflect the business success that can be achieved in cooperation with Údarás na Gaeltachta.”
For more information about the American Business Chamber and Network Symposium please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Today, Randox Biosciences and Dana Farber Cancer Institute highlighted the milestones achieved during their joint partnership. The collaborative partnership was the focus of the Boston-Ireland Precision Medicine Seminar with partners the City of Boston and the Massachusetts Life Science Center (MLSC).
The City of Boston Office of Economic Development and the Massachusetts Life Science Center are collaborating with Randox Biosciences on an innovative event to discuss the Boston-Ireland linkage in the field of Precision Medicine. The event will build business and science relationships between leading life science organizations. The program will highlight Boston as a global life science hub and illustrate why global leaders like Randox are seeking to build business partnerships in the area.
“Dana-Farber is a world-renowned name in the field of oncology and it is great to be working on this exciting new technology which is being developed in the lab of Dr. Novina.” Marshall Dunlop of Randox Laboratories said.
In the last year, the clinical diagnostics and life sciences provider Randox Laboratories has established a collaborative agreement with Dr. Carl Novina at the Dana-Farber Cancer Institute and Harvard Medical School. The goal of this collaboration is to develop therapeutic antibodies that will be incorporated into a platform technology that can reprogram patients’ immune systems to attack cancers.
“I am excited to work with Randox and use these important antibody technologies to help develop a novel cancer therapy that could potentially make a real difference for cancer patients.” said Dr. Carl Novina, Dana Farber Cancer Institute.
The Randox BioSciences and Dana Farber relationship highlights the close ties between Boston, Massachusetts and Ireland and provides another example of the strengths of Boston and Ireland in the life sciences sector. The life sciences industry continues to thrive all across Boston, from Longwood Medical Area – a world-famous medical campus with over 43,000 scientists, researchers, and staff including over 19,000 students – to the South Boston Waterfront District, the city’s newest cluster of high tech research, development, and manufacturing firms.
The City of Boston Chief of Economic Development John Barros said, “Mayor Martin J. Walsh is proud of Boston’s historic links with Ireland and the diverse economic bridges these links have created today. Within the life sciences alone, our researchers and businesses work together in new ways every day to shape how we treat, cure, and innovate together. By partnering with Randox and other leaders in the field, we continue to tackle global challenges together. Here at the City of Boston, we are committed to maintaining open doors as a global and welcoming city. These international partnerships will continue to play an active role in fostering opportunities for collaboration and growth.”
“Collaboration is the key ingredient that makes Massachusetts the best place in the world to innovate,” said Travis McCready, President & CEO of the MLSC. “It is great to see Randox collaborating with the leading scientists at the Dana-Farber Cancer Institute, toward the development of improved, targeted treatments for cancer patients.”
For more information about the Precision Medicine Seminar in Boston please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
A delegation led by the Cathaoirleach of Donegal County Council, Cllr Terence Slowey and the Mayor of Derry City and Strabane District Council, Cllr Hilary McClintock, are in Massachusetts this week as part of a joint endeavour to build relationships and forge partnerships.
Randox joined representatives from a wide range of sectors including education, food and drink distribution and manufacturing to attend meetings with a range of business contacts across the State of Massachusetts and key influencers.
Randox also made a number of key technology and business visits to Harvard and the State House and will participate in the Golden Bridges Conference.
Randox Senior Manager Mark Campbell said;
“The US is one of Randox’s most important markets and we are delighted to participate in this joint trade mission. There is clearly a strong regional and cultural link with Massachussets, and with facilities in Co Antrim and Co Donegal we seek to further develop our business relationship and increase exports. Our innovative diagnostic technologies have much to offer this US high tech hub – and will allow us to create further employment at home.”
In 2015 Randox announced plans to invest €25 million in Randox Teoranta, located in Dungloe in County Donegal. The investment included increasing staff numbers to 540 by 2020, offering world class careers in state-of-the-art R&D and manufacturing facilities. Randox also unveiled the Randox Science Park which will become the prime manufacturing and R&D facility in the UK. This new state of the art facility will generate 540 high value job opportunities over the next four years and will accelerate the development of new products into a wide range of clinical needs. These include various cancers, stroke, heart disease and neurodegenerative disorders, through more efficient, high specification manufacturing and the provision of state-of-the-art R&D laboratories.
Randox founder and CEO Dr Peter FitzGerald said;
“Our vision is to revolutionise healthcare through continuously improving diagnostic solutions. As well as employing locally we want to draw top class talent back to Donegal from the wider Irish diaspora and establish better relationships with the wider Massachusetts area. Randox offers world leading career opportunities to life scientists, electrical and mechanical engineers and software developers, and a chance to join a pioneering team creating diagnostic tests and analyser systems that save lives across the world.”
For more information on the delegation in Massachusetts please contact Randox PR via email: firstname.lastname@example.org
Randox’s Public Relations Executive, Amy McIlwaine, tells us about her time in New York State, working in Camp Wakonda (Homes for the Homeless)
We’re celebrating the bright and vibrant lives of Randox employees, and the way in which these inspiring individuals have helped to make Randox as great as it is today. Stay up to date with the #WeAreRandox hashtag on Twitter and Instagram to hear more stories.
We were discussing our most inspiring moments with Amy McIlwaine, Public Relations Executive of Randox Laboratories, this week. She told us a story of her time volunteering with children in New York State that we knew we had to share! We hope her story inspires you as much as it did us:
Here is Amy’s story:
“During my years at school and at University I worked as a part-time lifeguard in a local pool. I’ve always been quite ambitious, so, when the time came to graduate and I decided to do some overseas work, I applied to be Waterfront Director at a camp in New York State, called Camp Wakonda.
When I say the words ‘Summer camp’ to people they usually picture expensive facilities with music suites, maybe some horse stables and jet-skis, with a love-able rogue Joe Jonas lookalike thrown in for good measure, but Camp Wakonda wasn’t quite like that!
Camp Wakonda is a Summer camp that is run by the Homes for the Homeless organisation, and accepts children between 6 and 10 years old who are homeless and living in New York shelters.
The camp has limited resources, cabins with no electricity, and various (sometimes) friendly camp companions such as bears, chipmunks and rattlesnakes (we were in the middle of the woods). Children came to camp with very few belongings – sometimes even without a decent pair of shoes. But in spite of all that, it’s one of my favourite places on this earth. Being free from the stresses of everyday life (mind you, working with 90 children at a time brings a different kind of stress!) is wonderfully liberating and living in the middle of nature brings a certain serenity.
Although we had such limited resources, we had the time of our lives! You learn to be really creative – we had themed days throughout the summer like a Harry Potter banquet, a ‘Fairytales of Wakonda’ pantomime, and even Christmas on the 25th July! That one was probably my favourite – some of the children had never had a real Christmas before. I’m happy to admit that I welled up when I saw how incredibly excited they were at receiving just one small gift.”
Smiling from ear-to-ear, Amy went on to highlight the importance of the camp she worked in, in offering homeless children from New York the opportunity to just enjoy being kids, and how this inspired her:
“The spirit of the children, and the counsellors, at Camp Wakonda is something that I had not come across before, and have not come across since. For children who have had such a difficult upbringing, they came to camp with the biggest smiles on their faces, and the smallest things like three hot meals a day meant the world to them. It was great to see them free from the stresses of their unfortunate circumstances. For me, as their swimming teacher, nothing made me smile more than when a child came running up to me shouting ‘Miss Amy, I learned how to float today!’ or when a camper who had been so scared of the water finally got in and had a beaming smile from ear-to-ear when I handed them a swimming certificate. Many of the children had never left the city, and so had never experienced some of the things that we take for granted – like being able to see the stars in the sky at night.
I lived and worked in Wakonda for three months during 2014, and went back again in 2015, as Unit Leader of the older girl’s unit. I was responsible for counselor training, and the welfare of both the girl campers and the female counselors. When you’re practically working 24/7 for three months, the children become your entire life – everything that you do is with their needs in mind. Because of this, the children are so grateful of the time and attention that the counselors give them.
The work that Homes for the Homeless does for those kids is amazing, it really makes a difference to their lives, and I’m so glad that I have been part of it.”
Find out more about Camp Wakonda in this NY 1 News coverage video, here.
Randox wouldn’t be the innovative and caring healthcare company it is today without the hard work of young people with fresh perspectives and world experience like Amy – so we’re delighted that she has brought her enthusiasm to our team! We hope her story inspired you to take part in your community through volunteering. For us, we never stop. We’re helping to improve healthcare and diagnostics through consistent hard work, because for us, this means saving lives.
If you’re looking for a career in Business, Science or Engineering, let Randox be the next step in your adventure!
Follow us on Facebook, Twitter or Instagram or stay up-to-date with the hashtag #WeAreRandox. Visit our website to view our careers opportunities at Randox Laboratories.